Daito Pharmaceutical Co.,Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs. The company is also involved in the wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.
Frequently asked questions
What sector does Daito Pharmaceutical Co Ltd (4577) operate in?
Daito Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Daito Pharmaceutical Co Ltd (4577) current stock price?
As of the latest data, Daito Pharmaceutical Co Ltd stock price is ¥1,331, with a previous close of ¥1,326. Daito Pharmaceutical Co Ltd gained ¥5 in the last trading session, representing a 0.38% increase.
What is Daito Pharmaceutical Co Ltd (4577) current market capitalization?
Daito Pharmaceutical Co Ltd market cap is approximately 37.61 billion.
What is Daito Pharmaceutical Co Ltd (4577) Earnings Per Share (EPS)?
The trailing EPS is ¥107, and the forward EPS is ¥92.
What is Daito Pharmaceutical Co Ltd (4577) Price-to-Earnings (P/E) ratio?
Daito Pharmaceutical Co Ltd current P/E ratio is 12.39, with a forward P/E of 14.55.
What is Daito Pharmaceutical Co Ltd (4577) EBITDA?
Daito Pharmaceutical Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 2.00 billion.
Does Daito Pharmaceutical Co Ltd (4577) pay dividends?
Yes. Daito Pharmaceutical Co Ltd pays semiannual dividends with an annualized yield of 3.01% and an estimated annual payout of ¥40 per share.
When is the next ex-dividend date for Daito Pharmaceutical Co Ltd (4577)?
The next ex-dividend date is scheduled for November 28, 2026.
What is Daito Pharmaceutical Co Ltd (4577) beta (volatility) score?
Daito Pharmaceutical Co Ltd has a beta of 0.199, indicating lower volatility than the overall market.
